Veterinary Molecular Diagnostics Market Size, Share, Growth, and Regional Forecast, 2025 - 2032

The global veterinary molecular diagnostics market is expected to reach US$1,342.0 million in 2025 and US$2,375.5 million at a CAGR of 8.5% during the forecast period from 2025 to 2032. The global veterinary molecular diagnostics market is expanding steadily, driven by increasing awareness of zoonotic diseases, advancements in PCR and NGS technologies, and rising demand for accurate animal disease detection.

North America leads with a strong veterinary infrastructure, while Asia Pacific is growing fastest, fueled by expanding livestock sectors, government surveillance programs, and improved access to animal healthcare.

• Dominant Product: Consumables and Reagents, capturing nearly 59.4% market share, driven by frequent test usage, repeat purchases, and the growing adoption of PCR and NGS assay kits for disease detection and surveillance in both companion and livestock animals.
• Dominant Technology: PCR, holding nearly 43.1% share, dominates veterinary molecular diagnostics due to its high sensitivity, specificity, and speed in detecting bacterial, viral, and parasitic pathogens, enabling accurate diagnosis, surveillance, and effective outbreak management across animal species.
• Dominant Region: North America, accounting for about 38.7% share, leads the veterinary molecular diagnostics market due to advanced veterinary infrastructure, high pet healthcare spending, widespread adoption of PCR technologies, and strong disease surveillance and diagnostic capabilities.
• Investment Plans: Asia Pacific, focusing on expanding livestock surveillance networks, improving veterinary laboratory infrastructure, and fostering public-private collaborations for rapid test development and disease control initiatives.
• Market Drivers: Rising prevalence of zoonotic diseases, increasing pet ownership, advancements in PCR and sequencing technologies, and a stronger focus on food safety and animal welfare are key growth factors.
• Market Opportunity: Development of point-of-care molecular devices, integration of AI-based diagnostics, partnerships between veterinary clinics and biotech firms, and entry into emerging economies present strong expansion opportunities.

Driver - Increasing Pet Ownership and Livestock Health Investments

Increasing pet ownership and growing investments in livestock health are major drivers of the veterinary molecular diagnostics market. According to the American Veterinary Medical Association (AVMA) and the American Pet Products Association (APPA), around 66% of U.S. households, nearly 87 million owned a pet in 2023–24, up from 56% in 1988, reflecting a steady rise in demand for advanced veterinary diagnostics and preventive healthcare. Globally, the Food and Agriculture Organization (FAO) reports continuous growth in livestock populations, with over 1.5 billion cattle and 1 billion pigs recorded in 2022, highlighting the scale of disease surveillance required for food safety and trade. In India, livestock contributed over 30% to the agriculture and allied sector’s GVA in 2021–22, emphasizing the sector’s economic importance. These trends indicate that as both companion and farm animals grow in number and value, molecular diagnostic tools offering faster and more accurate disease detection are increasingly adopted to protect animal and public health.

Restraints - Lack of Skilled Veterinary Diagnostic Professionals

In the U.S., the American Veterinary Medical Association (AVMA) has identified over 243 rural veterinary shortage areas across 46 states in 2025, signaling pronounced workforce gaps. In the U.K., the Royal College of Veterinary Surgeons (RCVS) projects that the supply of veterinarians in industry and research will meet only ~84% and ~90% of demand, respectively, by 2035, highlighting chronic shortfalls in specialist roles necessary for advanced diagnostics. These shortages are particularly critical for molecular diagnostics, which require technicians with expertise in PCR, NGS and bioinformatics. Without sufficiently skilled personnel, uptake of new platforms is hindered, sample throughput is limited, and operational delays increase, ultimately slowing market growth and limiting access to cutting-edge veterinary testing services.

Opportunity - Expansion of Point-of-Care (POC) Testing Solutions

The expansion of point-of-care (POC) testing solutions is a major opportunity in the veterinary molecular diagnostics market, driven by the global shift toward rapid, field-based disease detection. According to the World Organization for Animal Health (WOAH), over 60% of emerging infectious diseases in humans originate from animals, underscoring the need for real-time surveillance at the animal level.

The U.S. Department of Agriculture (USDA) and Centers for Disease Control and Prevention (CDC) have emphasized on-site diagnostic capabilities to enable faster responses to zoonotic outbreaks such as avian influenza and African swine fever. Similarly, the Food and Agriculture Organization (FAO) supports mobile and portable lab initiatives in Asia and Africa to strengthen livestock disease control and prevent cross-border spread. These efforts reflect the growing role of POC molecular diagnostics, as portable PCR and LAMP platforms allow veterinarians to obtain accurate results within hours, improving animal health management and biosecurity.

By Product Insights

The Reagents & Consumables dominates the market with 59.4% share in 2025, because they are essential for every testing cycle and require continuous replenishment. Unlike instruments, which are one-time purchases, consumables such as PCR master mixes, primers, probes, and extraction kits are used repeatedly across diagnostic processes. According to the World Organisation for Animal Health (WOAH), more than 50% of global veterinary laboratories conduct molecular or PCR-based tests for disease surveillance, reflecting consistent demand for reagents and kits. The U.S. Department of Agriculture (USDA) and FAO also highlight that laboratory testing for diseases like avian influenza and foot-and-mouth disease involves frequent reagent use due to high sample throughput. Thus, recurring testing needs, ongoing disease monitoring, and biosecurity programs ensure that reagents and consumables remain the most consumed and revenue-generating segment in this market.

By Technology Insights

PCR dominates the market in the technology category due to its high sensitivity and broad pathogen-detecting capability. For instance, a study found that 92% of respondents used PCR regularly for equine pathogen detection in university and state veterinary labs. The Food and Agriculture Organization also notes that PCR-based diagnostics are widely used in animal health surveillance to compare sequence data and trace disease spread in livestock across Brazil, China, India, Mexico and South Africa. Because PCR tests can rapidly identify bacterial, viral or parasitic genetic material, many diagnostic workflows in veterinary labs rely on them, making PCR the preferred technology in this market.

North America Veterinary Molecular Diagnostics Market Trends

The North America region dominates the global market with a 38.7% share in 2025, due to its combination of high pet-ownership rates and advanced diagnostic infrastructure. In the U.S., approximately 94 million households own pets as of 2025, reflecting widespread demand for veterinary services and diagnostics. Moreover, federal agencies such as the United States Department of Agriculture (USDA) and the Centers for Disease Control and Prevention (CDC) run sophisticated animal-health surveillance and diagnostic programmes that rely heavily on molecular methods. This strong infrastructure, paired with animal-health awareness and investment, means that molecular diagnostics for companion animals, livestock and zoonotic disease are more rapidly adopted in North America than in many other regions.

Europe Veterinary Molecular Diagnostics Market Trends

Europe plays a critical role in the veterinary molecular diagnostics market because of its strong pet-ownership base and substantial livestock sector. Over 90 million European households (≈46 %) own at least one companion animal. At the same time, the region maintains large agricultural animal volumes, with approximately 133 million pigs and 74 million bovines at end of 2023. Such scale in both companion and production animals drives demand for advanced diagnostics. Moreover, the regulatory framework within the European Food Safety Authority (EFSA) and surveillance requirements for animal health support the adoption of molecular tests. Consequently, these factors make Europe an important and evolving region for veterinary molecular diagnostics.

Asia Pacific Veterinary Molecular Diagnostics Market Trends

The Asia Pacific region is the fastest-growing in the veterinary molecular diagnostics market, driven by booming livestock expansion and rising pet ownership. Livestock production in the region grew at approximately 3.5-5% annually, according to Food and Agriculture Organization data. Furthermore, countries like China report over 116 million pets in 2023 (58 million dogs and 60 million cats) contributing to increased veterinary service demand. These twin trends, larger livestock herds requiring disease surveillance, and rapidly growing companion-animal populations demanding wellness diagnostics, create a strong pull for molecular diagnostic tools (PCR, multiplex panels). Additionally, investments in diagnostic infrastructure and regulatory pushes for animal health further support the region’s accelerated growth.

Leading companies in the veterinary molecular diagnostics market are focusing on innovation and strategic expansion to meet growing diagnostic needs. Mergers, acquisitions, and collaborations remain key strategies to broaden global presence, enhance product portfolios, and develop advanced technologies such as real-time PCR and sequencing. These efforts enable firms to access new markets, strengthen veterinary partnerships, and leverage existing customer networks to support effective animal disease detection and surveillance.

Key Industry Developments:  

• In June 2025, Zoetis launched AI Masses, an AI-powered cytologic capability for its Vetscan Imagyst® platform, enhancing diagnostic precision for veterinarians. The new feature enabled automated detection and classification of cell masses, assisting in faster and more accurate cytology evaluations.
• In June 2025, bioMérieux launched VETFIRE™, a cutting-edge testing solution for equine infectious respiratory diseases, expanding its presence in veterinary diagnostics. The new platform was developed to provide rapid and precise identification of major respiratory pathogens affecting horses, enabling early intervention and better disease management.
• In February 2023, Thermo Fisher Scientific launched real-time PCR kits for infectious disease detection in India, expanding its molecular diagnostics portfolio in the region. The new kits were designed to provide rapid, accurate, and sensitive detection of key infectious pathogens, supporting India’s growing need for advanced diagnostic solutions.